Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DJ927

Known as: DJ 927, DJ-927 
A semi-synthetic orally-available taxane derivative with potent antineoplastic properties. DJ-927 binds to tubulin, promoting microtubule assembly… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
INTRODUCTION A phase I/II study was performed to assess the efficacy and toxicity of a new oral taxane in patients with recurrent… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2006
Review
2006
The clinical and commercial success of the taxanes and vinca alkaloids resulted in a drive to improve on current formulations and… Expand
Is this relevant?
2006
2006
3591 Background: DJ-927, a novel oral tubulin depolymerization inhibitor, causes apoptosis and DNA cell division arrest. It is… Expand
Is this relevant?
2006
2006
4081 Background: Most 1st-line combination chemotherapy regimens in pts with advanced GC include 5-FU. Taxanes are also active… Expand
Is this relevant?
2006
2006
17006 Background: For the treatment of NSCLC (1st and 2nd line) effective oral formulations of drugs are currently investigated… Expand
Is this relevant?
2004
2004
DJ-927, currently undergoing Phase I clinical trial, is a new orally effective taxane with potent antitumor effects. The… Expand
  • figure 2
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2004
2004
2028 Background: DJ-927, a novel semi-synthetic taxane and a poor substrate of P-glycoprotein (Pgp), is orally bioavailable and… Expand
Is this relevant?
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2003
2003
DJ-927 is a novel taxane, which was selected for high solubility, non-neurotoxicity, oral bioavailability, and potent antitumor… Expand
Is this relevant?